Paul Bartlett Joins Rho Ventures as a Partner

Palo Alto, CA
March 26, 2007

Rho Capital Partners today announced that Paul Bartlett has joined Rho Ventures as a Partner in its California office. Mr. Bartlett will focus on late stage and growth equity investments in the technology sector.

Prior to joining Rho Ventures, Mr. Bartlett spent seven years at the Sprout Group and left as a general partner in 1996. He then spent seven years in either CEO or COO positions with various public companies in the information technology sector, including Quintus and Critical Path. He returned to venture capital investing as an executive-in-residence at New Enterprise Associates and most recently was a private equity investor as a Managing Director at One Equity Partners, a division of J.P. Morgan Bank. Mr. Bartlett received his bachelor’s degree in Economics from Princeton University, and his Master of Business Administration from Stanford University.

Rho Ventures, a division of Rho Capital Partners, has been backing emerging companies primarily in the U.S. since its inception in 1981. Venture capital funds under management currently exceed $1.4 billion. Rho Ventures has invested in over 175 emerging companies and helped build market leaders across many high growth industries. The firm is currently investing Rho Ventures V, a $425MM fund launched in 2005. Previous investments include Ciena Corporation, Compaq Computer, Diversa, Human Genome Sciences, iVillage, Leukosite (currently part of Millenium Pharmaceuticals), MedImmune, Senomyx, Tripod (currently part of Lycos), Vanda Pharmaceuticals, Vicuron and Yantra.

Rho Capital Partners is an investment firm that manages capital for institutions and wealthy families on a global basis. Rho Capital Partners' activities include investing in emerging companies in the information technology, communications, and healthcare sectors; venture capital and specialized private equity funds; and private equity transactions. Rho Capital Partners has offices in New York, Palo Alto and Montreal, Canada.